slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 20,011-20,040
Pages 2,605
Rows per page 30
Component
20,011-20,040 of 78,129
33
Uses a before-after-bridge framework to highlight the growth in Fibrosis stage 2-4 prevalence.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction2 hits
45
The slide title mentions week 12, but the charts explicitly label week 24. This is a common discrepancy in clinical trial decks where data is presented across multiple time points.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
48
P-values are calculated using Cochran-Mantel Haenszel test vs placebo.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
52
The slide highlights the efficacy of MGL-3196 in NASH treatment using MRI-PDFF as a biomarker.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 2 hits
22
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement2 hits
23
Azerion | Investor Presentation Deck | 27 slidesAzerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement2 hits
24
Includes a comparison of Q2 2021 vs Q2 2022 and H1 2021 vs H1 2022.Azerion | Investor Presentation Deck | 27 slides · Azerion
Pitch deck Investor relations Beat · Ultimate Achievement2 hits
12
The slide uses two charts to demonstrate market validation: one for investment growth and one for pipeline expansion.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Golden Circle2 hits
30
BenevolentAI | Investor Day Presentation Deck | 74 slidesBenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
55
The slide contains four dose-response curves (a-d) and two box-and-whisker plots (e-f) showing cytokine levels in patient biopsies.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
57
The slide uses a combination of a biological pathway diagram, scatter plots for differential expression, and a line chart for tissue-specific expression.BenevolentAI | Investor Day Presentation Deck | 74 slides · BenevolentAI
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
07
The chart highlights Boohoo Group entities in pink, while others are in purple or blue. The supplemental box shows growth in market share and penetration from HY20 to HY23.Boohoo | Results Presentation Deck | 41 slides · boohoo group plc
Conference presentation Investor relations Beat · Need2 hits
15
Broadridge Financial Solutions | Results Presentation Deck | 37 slidesBroadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
17
The slide uses two different chart types to show total growth and segment-specific growth.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
18
The slide uses a donut chart to represent the platform scale and a bar chart to show growth over time.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test2 hits
23
The slide uses two distinct bar charts to show sales performance and backlog growth.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · Action2 hits
25
Includes footnotes 1-4 detailing capital allocation categories and return definitions.Broadridge Financial Solutions | Results Presentation Deck | 37 slides · Broadridge
Conference presentation Investor relations Beat · Action2 hits
06
Includes a bar chart for loan balances and a pie chart for portfolio composition.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
11
The slide uses a bar chart for historical growth and a pie chart for current composition.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
15
Includes dividend history, share repurchases, and regulatory capital cushion.Central Pacific Financial | Investor Presentation Deck | 21 slides · Central Pacific Financial
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
21
Includes a footnote regarding bank-level data usage for 2017 and 2018.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 2 hits
24
Data points represent annual figures except for YTD 2022.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 2 hits
28
Includes footnotes regarding non-GAAP measures and specific period adjustments.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 2 hits
20
The slide compares the library against a benchmark (IMAB027) in terms of reactivity and cytotoxicity.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction2 hits
04
Includes market sizing data and clinical characteristics of the target patient segment.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 2 hits
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectively, creating a market need.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · ComplicationLoop · Cost Of Inaction2 hits
11
Includes two charts: a bar chart for SVR achievement and a waterfall plot for median percentage change in spleen volume.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
12
Includes a bar chart for response rates and a waterfall plot for individual patient symptom changes.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
14
Data presented as median values with interquartile ranges (IQR).CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence2 hits
17
The slide compares two different clinical trial datasets (PERSIST-2 vs MOMENTUM) to highlight efficacy.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 2 hits